Revenue growth is due to growth in Teva's US generics business, the company's main market, among other things due to sales of ...

We came across a bullish thesis on Teva Pharmaceutical Industries Limited (TEVA) on Kontra Investment Xchange’s Substack by ...

The collaboration between the two companies reflects ongoing efforts to enhance drug development, the CEO of Immunai said.

Deckers Brands DECK continues to operate at a high level as its brands, including UGG and HOKA, remain in demand. This Zacks ...

Alvotech's commercial partners include Teva Pharmaceuticals, a US affiliate of Teva Pharmaceutical Industries Ltd. (US), ...

Chicago, IL –November 13, 2024 – Zacks Equity Research shares Deckers Brands DECK, as the Bull of the Day and Commercial ...

The Food and Drug Administration (FDA) has approved a new presentation of Selarsdi ™ (ustekinumab-aekn), a biosimilar to Stelara ® (ustekinumab), expanding the product’s indications to include ...

In closing its therapeutics division and laying off 200 people, 23andMe ended an audacious bet it made nearly a decade ago — ...

A jury found McKesson and Cencora liable for $266 million in damages to the city of Baltimore for fueling the opioid crisis.

A: The capacity utilization is around 40%, and the revenue contribution from the Teva facility this quarter is approximately 100 crores. - CEO Q: Can you provide details on the new product launches in ...

Total Revenues in the first nine months of 2024 increased by $300 million compared to same period in 2023, to $339 million, with Q3 revenues contributing $103 millionProduct revenues in the first nine ...

Researchers are exploring how small airway abnormalities in younger smokers could help identify who is at risk of developing COPD and establish how the chronic lung disease progresses.